Myc

Gene transcription through Myc family members in eukaryotic cells.
[10440528] Jpn J Pharmacol 80(2): 103-9 (1999)

Regulation of Myc: Max complex formation and its potential role in cell proliferation.
[1306304] Tohoku J Exp Med 168(2): 195-202 (1992)

c-Myc oncoprotein: a dual pathogenic role in neoplasia and cardiovascular diseases?
[11988837] Neoplasia 4(3): 185-90 (2002)

Myc goes global: new tricks for an old oncogene.
[17545579] Cancer Res 67(11): 5061-3 (2007)

c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry.
[19448666] Oncogene 28(27): 2485-91 (2009)

The proto-oncogene c-myc in hematopoietic development and leukemogenesis.
[12032779] Oncogene 21(21): 3414-21 (2002)

MYC oncogenes and human neoplastic disease.
[10378696] Oncogene 18(19): 3004-16 (1999)

The role of c-myc in cellular growth control.
[10378694] Oncogene 18(19): 2988-96 (1999)

Mechanisms of apoptosis by c-Myc.
[10378693] Oncogene 18(19): 2967-87 (1999)

The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
[10378692] Oncogene 18(19): 2955-66 (1999)

New Myc-interacting proteins: a second Myc network emerges.
[10378691] Oncogene 18(19): 2942-54 (1999)

Mysterious liaisons: the relationship between c-Myc and the cell cycle.
[10378690] Oncogene 18(19): 2934-41 (1999)

Myc-mediated transformation: the repression connection.
[10378689] Oncogene 18(19): 2925-33 (1999)

The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation.
[10378688] Oncogene 18(19): 2916-24 (1999)

The proto-oncogene c-myc and apoptosis.
[9916997] Oncogene 17(25): 3351-7 (1998)

Key signalling nodes in mammary gland development and cancer: Myc.
[19849814] Breast Cancer Res 11(5): 210 (2009)

The molecular role of Myc in growth and transformation: recent discoveries lead to new insights.
[9619443] FASEB J 12(9): 633-51 (1998)

Function of the c-Myc oncoprotein.
[1521738] FASEB J 6(12): 3065-72 (1992)

c-Myc blazing a trail of death: coupling of the mitochondrial and death receptor apoptosis pathways by c-Myc.
[17914284] Cell Cycle 6(20): 2464-72 (2007)

The life cycle of C-myc: from synthesis to degradation.
[15467447] Cell Cycle 3(9): 1133-7 (2004)

E2F1 and c-Myc in cell growth and death.
[12851485] Cell Cycle 2(4): 333-8 (2003)

c-Myc oncoprotein: cell cycle-related events and new therapeutic challenges in cancer and cardiovascular diseases.
[12851483] Cell Cycle 2(4): 325-8 (2003)

New light on Myc and Myb. Part I. Myc.
[2269425] Genes Dev 4(12A): 2025-35 (1990)

The ins and outs of MYC regulation by posttranslational mechanisms.
[16987807] J Biol Chem 281(46): 34725-9 (2006)

c-Myc target genes involved in cell growth, apoptosis, and metabolism.
[9858526] Mol Cell Biol 19(1): 1-11 (1999)

"Myc'ed messages": myc induces transcription of E2F1 while inhibiting its translation via a microRNA polycistron.
[17784791] PLoS Genet 3(8): e146 (2007)

HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation.
[17692803] Cancer Cell 12(2): 108-13 (2007)

The great MYC escape in tumorigenesis.
[16169462] Cancer Cell 8(3): 177-8 (2005)

Myc-Is this the oncogene from Hell?
[12124167] Cancer Cell 1(5): 406-8 (2002)

Myc: a weapon of mass destruction.
[15084254] Cell 117(2): 153-6 (2004)

Why myc? An unexpected ingredient in the stem cell cocktail.
[18371417] Cell Stem Cell 2(1): 18-21 (2008)

Cell growth: downstream of Myc - to grow or to cycle?
[10607581] Curr Biol 9(24): R936-8 (1999)

Cell cycle: on target with Myc.
[8994810] Curr Biol 6(12): 1553-6 (1996)

Making decisions through Myc.
[11223030] FEBS Lett 490(3): 153-62 (2001)

Cdk2: a key regulator of the senescence control function of Myc.
[20445224] Aging (Albany NY) 2(4): 244-50 (2010)

c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis.
[21278493] Cancer Biol Ther 11(7): 615-26 (2011)

Regulation of Myc by miR-34c: A mechanism to prevent genomic instability?
[20603603] Cell Cycle 9(14): 2726-30 (2010)

A therapeutic role for targeting c-Myc/Hif-1-dependent signaling pathways.
[20404562] Cell Cycle 9(9): 1722-8 (2010)

Feedback regulation of c-Myc by ribosomal protein L11.
[18032916] Cell Cycle 6(22): 2735-41 (2007)

Turning the tables: Myc activates Wnt in breast cancer.
[17726380] Cell Cycle 6(21): 2625-7 (2007)

3D view to tumor suppression: Lkb1, polarity and the arrest of oncogenic c-Myc.
[19221484] Cell Cycle 8(5): 716-24 (2009)

Carrot and stick: HIF-alpha engages c-Myc in hypoxic adaptation.
[18188166] Cell Death Differ 15(4): 672-7 (2008)

The role of bystin in embryo implantation and in ribosomal biogenesis.
[17917702] Cell Mol Life Sci 65(1): 92-9 (2008)

The multi-tasking P-TEFb complex.
[18513937] Curr Opin Cell Biol 20(3): 334-40 (2008)

The ups and downs of Myc biology.
[19962879] Curr Opin Genet Dev 20(1): 91-5 (2010)

MYC-induced cancer cell energy metabolism and therapeutic opportunities.
[19861459] Clin Cancer Res 15(21): 6479-83 (2009)

The multifaceted role of MTDH/AEG-1 in cancer progression.
[19723648] Clin Cancer Res 15(18): 5615-20 (2009)

Disrupting polyamine homeostasis as a therapeutic strategy for neuroblastoma.
[19789308] Clin Cancer Res 15(19): 5956-61 (2009)

Tipping the balance: Cdk2 enables Myc to suppress senescence.
[20713526] Cancer Res 70(17): 6687-91 (2010)

Rethinking the Warburg effect with Myc micromanaging glutamine metabolism.
[20086171] Cancer Res 70(3): 859-62 (2010)

Tumor dormancy and MYC inactivation: pushing cancer to the brink of normalcy.
[15930260] Cancer Res 65(11): 4471-4 (2005)

The role of Myc-induced protein synthesis in cancer.
[19934336] Cancer Res 69(23): 8839-43 (2009)

Acting locally and globally: Myc's ever-expanding roles on chromatin.
[19773445] Cancer Res 69(19): 7487-90 (2009)

Myc in model organisms: a view from the flyroom.
[16916612] Semin Cancer Biol 16(4): 303-12 (2006)

Targeting c-Myc as a novel approach for hepatocellular carcinoma.
[21160952] World J Hepatol 2(1): 16-20 (2010)

Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc.
[16925946] Neoplasia 8(8): 630-44 (2006)

Myc proteins as therapeutic targets.
[20101214] Oncogene 29(9): 1249-59 (2010)

Transcriptional repression: the dark side of myc.
[21779459] Genes Cancer 1(6): 580-6 (2010)

A tumor suppressor role for PP2A-B56alpha through negative regulation of c-Myc and other key oncoproteins.
[18246411] Cancer Metastasis Rev 27(2): 147-58 (2008)

Crosstalk between c-Myc and ribosome in ribosomal biogenesis and cancer.
[18773413] J Cell Biochem 105(3): 670-7 (2008)

Transcriptional targets for pituitary tumor-transforming gene-1.
[19433493] J Mol Endocrinol 43(5): 179-85 (2009)

The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming.
[19664987] Cell Stem Cell 5(2): 141-9 (2009)

Myc transcription factors: key regulators behind establishment and maintenance of pluripotency.
[21082893] Regen Med 5(6): 947-59 (2010)

Role of helix-loop-helix proteins during differentiation of erythroid cells.
[21282467] Mol Cell Biol 31(7): 1332-43 (2011)

The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
[20922462] Cancer Metastasis Rev 29(4): 613-39 (2010)

C-Myc induced compensated cardiac hypertrophy increases free fatty acid utilization for the citric acid cycle.
[22828478] J Mol Cell Cardiol 55():156-64 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Myc.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Myc.php on line 92